Preparation of poly(DL‐lactide‐co‐glycolide) nanoparticles without surfactant

The preparation of poly(DL ‐lactide‐co‐glycolide) (PLGA) nanoparticles was performed by a dialysis method without surfactant or emulsifiers. The size of the PLGA nanoparticles prepared from dimethylacetamide (DMAc) as an initial solvent was smaller than that from acetone. The sizes of the PLGA nanoparticles from DMAc and acetone were 200.4 ± 133.0 and 642.3 ± 131.1 nm, respectively. The effects of the initial solvent selected to dissolve the copolymer and the lactide:glycolide ratio were investigated. The PLGA nanoparticles were spherical as revealed by the results of scanning electron microscopy and transmission electron microscopy observations. From these results it was shown that PLGA nanoparticles could be formed by the dialysis method without surfactant. The drug‐loading contents and efficiency were also dependent on the lactide:glycolide ratio and initial feeding amount of the drug. A higher lactide ratio resulted in higher drug loading and higher loading efficiency. However, a higher initial feeding amount of the drug resulted in higher drug loading and lower loading efficiency. Clonazepam was released for at least 2 days and the release rate was slower with a higher lactide:glycolide ratio and a larger amount of drug‐loading nanoparticles than that with a lower lactide:glycolide ratio and a smaller amount of drug‐loading nanoparticles. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 80: 2228–2236, 2001     

Preparation and properties of a biodegradable polymer as a novel drug delivery system

Poly (DL ‐lactic acid‐co‐glycolic acid)‐co‐poly(ethylene glycol) was synthesized by bulk ring‐opening polymerization of DL ‐lactide/glycolide/poly(ethylene glycol) using stannous chloride as an initiator. The molecular structure of the copolymer was analyzed by IR, ¹H NMR, and DSC. The degradation behavior of copolymer was assayed by the reduction of molecular weight, the loss‐in‐mass, and the changes of pH value for degradation medium. The different contents of PGA and PEG in the molecules of the copolymer could control the degradation rate of polymer. Human Serum Albumin (HSA) was chosen as the model hydrophilic drug and encapsulated in the copolymer. The HA‐loaded copolymer microspheres were characterized by the diameter, diameter distribution of the microspheres, and the loading efficiency. © 2003 Wiley Periodicals, Inc. J Appl Polym Sci 90: 3150–3156, 2003     

Novel thermosensitive hydrogel composites based on poly(d,l‐lactide‐co‐glycolide) nanoparticles embedded in poly(n‐isopropyl acrylamide) with sustained drug‐release behavior

To reach sustained drug release, a new composite drug‐delivery system consisting of poly(d,l ‐lactide‐co‐glycolide) (PLGA) nanoparticles (NPs) embedded in thermosensitive poly(N‐isopropyl acrylamide) (PNIPAAm) hydrogels was developed. The PNIPAAm hydrogels were synthesized by free‐radical polymerization and were crosslinked with poly(ethylene glycol) diacrylate, and the PLGA NPs were prepared by a water‐in‐oil‐in‐water double‐emulsion solvent‐evaporation method. The release behavior of the composite hydrogels loaded with albumin–fluorescein isothiocyanate conjugate was studied and compared with that of the drug‐loaded neat hydrogel and PLGA NPs. The results indicate that we could best control the release rate of the drug by loading it to the PLGA NPs and then embedding the whole system in the PNIPAAm hydrogels. The developed composite hydrogel systems showed near zero‐order drug‐release kinetics along with a reduction or omission of initial burst release. The differential scanning calorimetry results reveal that the lower critical solution temperature of the developed composite systems remained almost unchanged (<1°C increase only). Such a characteristic indicated that the thermosensitivity of the PNIPAAm hydrogel was not distinctively affected by the addition of PLGA NPs. In conclusion, an approach was demonstrated for the successful preparation of a new hybrid hydrogel system having improved drug‐release behavior with retained thermosensitivity. The developed systems have enormous potential for many biotechnological applications. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 40625.     

Comparison of the degradation and release behaviors of poly(lactide‐co‐glycolide)–methoxypoly(ethylene glycol) microspheres prepared with single‐ and double‐emulsion evaporation methods

The purpose of this study was to compare the degradation and release behaviors of poly(lactide‐co‐glycolide) (PLGA)–methoxypoly(ethylene glycol) microspheres fabricated by the single‐emulsion evaporation method (DEEM) and double‐emulsion evaporation methods (DEEM). Vancomycin and mizolastine were used as the hydrophilic and hydrophobic model drugs, and they were encapsulated into microspheres through DEEM and SEEM, respectively. The two types of microspheres were similar in size distribution, but the mizolastine‐loaded microspheres showed a much higher encapsulation efficiency than those loaded with vancomycin. Scanning electron microscopy, size, and molecular weight (Mw) analyses during the degradation revealed that the microspheres fabricated by DEEM underwent a bulk degradation process and showed a faster MW reduction rate during the early degradation period than the microspheres fabricated by SEEM, which exhibited a surface‐to‐bulk degradation process according to the Mw and morphological changes. The mass loss rates of the two types of microspheres were similar, but the mean size decrease rates showed a little difference. The mizolastine‐loaded microspheres exhibited an approximately linear release profile after the initial burst release, whereas the vancomycin‐loaded microspheres showed a more severe burst release, a faster release rate, and thus, a shorter time to full release. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 41943.     

In vitro degradation and release profiles of poly‐DL‐lactide‐poly(ethylene glycol) microspheres with entrapped proteins

Poly‐DL ‐lactide (PLA) and poly‐DL ‐lactide‐poly(ethylene glycol) (PELA) were produced by bulk ring‐opening polymerization using stannous chloride as initiator. PLA, PELA microspheres, and PELA microspheres containing the outer membrane protein (OMP) of Leptospira interrogans with the size of 1.5–2 μm were prepared by a solvent evaporation process. In vitro degradation and release tests of PLA, PELA, and OMP‐loaded PELA microspheres were performed in pH 7.4 buffer solution at 37°C. Quantitatively, the degree of degradation was monitored by detecting the molecular weight reduction, by evaluating the mass loss and the apparent degradation rate constant, and by determining the intrinsic viscosity and poly(ethylene glycol) content of retrieved polymer, while the release profile was assessed by measuring the amount of protein presented in the release medium at various intervals. Qualitatively, the morphological changes of microspheres were observed with scanning electron micrography. The observed relative rates of mass loss versus molecular weight reduction are consistent with a bulk erosion process rather than surface erosion for PELA microspheres. The introduction of hydrophilic poly(ethylene glycol) domains in copolymer PELA and the presence of OMP within microspheres show critical influences on the degradation profile. The OMP‐loaded PELA microspheres present triphasic release profile and a close correlation is observed between the polymer degradation and the OMP release profiles. It is suggested that the polymer degradation rate, protein diffusion coefficient, and the water‐swollen structure of microspheres matrix commonly contribute to the OMP release from PELA microspheres. © 2000 John Wiley & Sons, Inc. J Appl Polym Sci 78: 140–148, 2000     

Production of double‐walled nanoparticles containing meloxicam

Double‐walled nanospheres, containing meloxicam, were fabricated with poly‐(D,L ‐lactide‐co‐glycolide) (PLGA) and poly(L ‐lactide) (PLLA) using the solvent evaporation technique. This article discusses the effect of formulation variables [sonication power, sonication time, concentration of poly(vinyl alcohol), organic/aqueous volume ratio in the first emulsion] on the production of double‐walled nanospheres. The involved phase separation of these two polymers was investigated using differential scanning calorimetry. Double‐walled microspheres containing meloxicam were also produced to determine the composition of the shell and core polymer, based on different solubilities of polymers in ethyl acetate, and to examine the inner morphology and drug distribution using optical and fluorescence microscopy. The produced microparticles have shown a double‐walled structure with meloxicam solubilized in the PLGA‐rich phase. Therefore, adjusting the selected formulation variables and using a mass ratio of 1:1 PLLA/PLGA, double‐walled nanospheres where meloxicam is dispersed within the core can be produced. POLYM. ENG. SCI., 2013. © 2012 Society of Plastics Engineers     

Thermosensitive nanoparticles prepared from poly(N‐isopropylacrylamide‐acrylamide‐vinilpyrrolidone) and its blend with poly(lactide‐co‐glycolide) for efficient drug delivery system

Temperature‐responsive polymers have become increasingly attractive as carrier for the injectable drug delivery systems. In the present work, we have studied the preparation of poly(N‐isopropylacrylamide‐acrylamide‐vinilpyrrolidone) (NIPAAm‐AAm‐VP terpolymer) nanoparticulated terpolymer and its blend with poly(lactide‐co‐glycolide, PLGA; molar ratio of lactide/glycolid 1/3). Thermosensitive terpolymer, poly(NIPAAm‐AAm‐VP) was prepared by free‐radical polymerization in aqueous solution. The nanoparticles of poly(NIPAAm‐AAm‐VP) and its blend with PLGA containing naltrexone were prepared using the evaporation and w/o emulsion‐solvent evaporation methods, respectively. Nanoparticles prepared from terpolymer‐PLGA blend at low polymer concentration (5%) shows larger particle size (>300 nm) and higher drug content%. Various types of nanoparticles showed a burst release of less than 10% after 24 h . The results suggest that by regulating different variables, desired release profiles of naltrexone can be achieved using a blend of PLGA‐poly(NIPAAm‐AAm‐VP) nanoparticulate system. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Effect of additives on release profile of leuprolide acetate in an in situ forming controlled‐release system: In vitro study

In situ forming drug delivery system is prepared by phase inversion technique using poly (D ,L ‐lactic‐co‐glycolide) and leuprolide acetate dissolved in N‐methyl‐2‐pyrrolidone. The effects of ethyl heptanoate and glycerol additives are important determinant as rate modifying agents on the drug release kinetics in biodegradable in situ forming porous systems of poly(D ,L ‐lactide‐co‐glycolide) (PLGA) in N‐methyl‐2‐pyrrolidone (NMP). The release performance and porous structure morphology are investigated by scanning electron microscopy and UV–visible spectroscopy techniques to study the effect of additives. The experimental results exhibit the crucial role of ethyl heptanoate and glycerol at different loadings (1, 3, and 5% w/w) on release profile of leuprolide acetate loaded on poly(D ,L ‐lactide‐co‐glycolide)hydroxylated (PLGA‐H). Both additives at different concentrations reduce the burst effect, while increasing duration of drug release. Ethyl heptanoate, however, shows stronger effect than glycerol. The results of morphological studies show that ethyl heptanoate reduces the porosity of the polymer surface and interconnected tear‐like structures of the bulk disappear while the sponge‐like structures are observed. In this system glycerol reduces the surface porosity intensively, while the interconnected tears change into channel‐like structures. Therefore, morphological results confirm the effect of additives on leuprolide release profile. © 2007 Wiley Periodicals, Inc. J Appl Polym Sci 2008     

Tamoxifen‐loaded microspheres based on mixtures of poly(D,L‐lactide‐co‐glycolide) and poly(D,L‐lactide) polymers: Effect of polymeric composition on drug release and in vitro antitumoral activity

Mixtures of different bioerosionable polyesters were used to prepare microparticulated tamoxifen delivery systems to achieve anticancer effects in breast malignant cancer cells. Tamoxifen (TMX) was included into microspheres (MS) formulated via spray‐drying. Mixtures of poly(D ,L ‐lactide‐co‐glycolide) (PLGA) of different lactide/glycolide proportions (50 : 50 and 75 : 25) and poly(D ,L ‐lactic acid) (PLA) were used. The average diameter of the resultant TMX‐loaded microparticles was in the range 1.04 ± 0.51–1.55 ± 0.95 μm. The encapsulation efficiency of TMX was between 97.8% [48.9 ± 0.1 TMX (μg)/MS (mg)] and 69.6% [36.6 ± 0.1 TMX (μg)/MS (mg)] depending on the polymeric composition of the formulation. Drug burst effect was not observed. TMX was released from the polymeric matrices in a sustained release manner between 11 and 58 days depending on polymeric composition of microspheres. TMX‐loaded microspheres showed high efficacy in causing cell death in MCF7 breast malignant cancer cells. Thus, these TMX‐loaded PLGA‐based microspheres hold potential to treat breast malignant cancer cells. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012     

Effect of composition on morphology structure and cell affinity of poly(caprolactone‐co‐glycolide)‐co‐poly(ethylene glycol) microspheres

Poly(caprolactone‐co‐glycolide)‐co‐poly(ethylene gylcol) copolymers (PCEG) with various composition were synthesized by copolymerization of GA, CL, and PEG. PCEG microspheres were fabricated by oil‐in‐water (o/w) emulsion and solvent‐evaporation technique. Effect of chemical composition on hydrophilicity, crystallinity, and degradation of the PCEG was investigated. It was demonstrated that morphology structure of the microspheres was greatly influenced by chemical composition and hydrophilicity of the PCEG polymer. PCEG microspheres could change from a smooth structure to a regular porous structure and an irregular structure. Moreover, the pore size of them increased with increment of PEG content and length. Cell attachment and growth on the PCEG microspheres were evaluated by using mouse NIH 3T3 fibroblasts as model cells in vitro. The result showed that the PCEG microspheres with large porous structure were more favorable for cell attachment and growth. Thus the PCEG microspheres with rapid degradation rate and large porous structure possess potential use as injectable scaffolds in tissue engineering. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2016 , 132, 42861.     

Preparation and drug release behaviors of 5‐fluorouracil loaded poly(glycolide‐co‐lactide‐co‐caprolactone) nanoparticles

5‐Fluorouracil (5‐Fu) loaded poly(glycolide‐co‐lactide‐co‐caprolactone) (PGLC) nanoparticles were prepared by modified spontaneous emulsification solvent diffusion method (modified‐SESD method) and characterized by dynamic light scattering, scanning electron microscopy and ¹H NMR determination. It was found that the obtained nanoparticles showed near spherical shape and was controllable with the radius range of 30–100 nm. Compared with the nanoparticles prepared by polylactide and poly (lactide‐co‐glycolide) (PLGA) under the similar preparation condition, yield of PGLC nanoparticles was the highest, which reached to about 100%. On the other hand, drug entrapment efficiency of PGLC nanoparticles was also higher than that of PLGA and PLLA nanoparticles. 5‐Fu release behavior of PGLC nanoparticles in vitro showed that 5‐Fu release of PGLC nanoparticles showed a near zero‐order release profile, and 5‐Fu release rate of PGLC nanoparticles was faster than that of PLLA and PLGA nanoparticles. According to degradation behavior of PGLC nanoparticles, it could be proposed that the kinetic of degradation controlled release played an important role in the release process of PGLC nanoparticles. It revealed that the PGLC nanoparticles could be a promising drug carrier. © 2007 Wiley Periodicals, Inc. J Appl Polym Sci, 2007     

Preparation and characterization of electrospun,biodegradable membranes

Nonwoven, biodegradable membranes fabricated by electrospinning have recently attracted a great deal of attention for biomedical applications. In this study, microporous, nonwoven membranes of poly(L ‐lactide) and its copolymers and blends were fabricated through electrospinning. The structures and morphologies of the electrospun membranes were investigated with scanning electron microscopy, differential scanning calorimetry, and X‐ray diffraction. Different polymer membranes, incorporated with carmofur, were fabricated, and their drug release profiles were investigated. Scanning electron microscopy images showed that the fiber diameters were down to the nanometer range. The diameters and morphologies of thenanofibers depended on processing parameters such as the solution properties (concentration and polymer molecular weight), applied electric voltage, solution feeding rate, and needle diameter. Differential scanning calorimetry showed that the crystallinity of the electrospun membranes was lower than that of the cast film. For all the membranes incorporated with the drug, there was a burst release in the first 10 h of incubation in phosphate‐buffered saline at 37°C. Poly(glycolide‐co‐lactide) membranes showed faster and more complete drug release than poly(L ‐lactide), and this could be attributed to its faster degradation. The incorporation of polylactide–poly(ethylene glycol) could shorten the drug release time. A combination of suitable degradable biomaterials with an appropriate electrospinning process could be useful in the fabrication of a new kind of membrane suitable for different biomedical applications such as tissue engineering and drug delivery. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2008     

Novel blends of poly[bis(glycine ethyl ester) phosphazene] and polyesters or polyanhydrides: compatibility and degradation characteristics in vitro

Poly[bis(glycine ethyl ester)phosphazene] (PGP) was blended with poly(D ,L ‐lactide) (PLA), poly(D ,L ‐lactide‐co‐glycolide) (80:20 by mole) (PLGA), poly(sebacic anhydride) (PSA) and poly(sebacic anhydride‐co‐trimellitylimidoglycine)‐block‐poly(ethylene glycol) (30:50:20 by mole) (PSTP) in various ratios using a solvent‐mixing technique. The compatibility of these blends has been evaluated by DSC, FTIR and phase contrast microscopy. The results indicated that PGP is completely incompatible with PLA, but partially compatible with PLGA and PSTP, which may be attributed to a hydrogen bonding effect. Degradation experiments have been conducted in distilled water at 37 °C and show that the blend degradation rate can be regulated by adjusting the PLGA or PSTP content of the blends. PGP/PLGA (70:30 by wt) slabs took 120 days to disappear completely, while PGP/PSTP (70:30 by wt) slabs needed only 20 days. These findings suggest that blends of PGP and PLGA or PSTP may be used as matrices for drug controlled release and for other potential biomedical applications. © 2000 Society of Chemical Industry     

Preparation and characterization of poly‐DL‐lactide–poly(ethylene glycol) microspheres containing λDNA

Polylactide (PLA) and a block copolymer, poly‐DL ‐lactide–poly(ethylene glycol) (PELA) were synthesized by bulk ring‐opening polymerization initiated by stannous chloride. A linear DNA molecule, λDNA, was used as the model DNA. PLA, PELA, λDNA‐loaded PLA and PELA microspheres were prepared by the solvent‐extraction method based on the formation of multiple w₁/o/w₂ emulsion. The particle‐size distribution, surface morphology, and DNA loading characterized the microspheres. The mean diameter of λDNA‐loaded PELA microspheres was proved to be 3.5 μm. The integrity of the λDNA molecules, after preparing the microspheres, was determined by agarose gel electrophoresis. The result suggested that most of the λDNA molecules could retain their integrity after being encapsulated by PELA. The PELA microspheres could also prevent λDNA from being degraded by DNase. The in vitro degradation and release of PLA, PELA, and λDNA‐loaded PELA microspheres were carried out in a pH 7.4 buffer solution at 37°C. Quantitatively, evaluating the molecular weight reduction, the mass loss, the particle‐size changes, and the particle‐size distribution changes also monitored the degree of degradation. The release profile was assessed by measurement of the amount of λDNA present in the release medium at determined intervals. The degradation profiles of the PELA microspheres were quite different from those of the PLA microspheres. The introduction of the hydrophilic poly(ethylene glycol) domain in PLA and the presence of λDNA within the microspheres exhibit the apparent influence on the degradation and release profiles. A biphasic release profile was proved, that is, an initial burst release during the first days, then a gradual release. It was demonstrated that the PELA microspheres could be used potentially as a controlled release‐delivery system for λDNA. © 2002 Wiley Periodicals, Inc. J Appl Polym Sci 86: 2557–2566, 2002     

In situ encapsulation of hydrogel in ultrafine fibers by suspension electrospinning

Composite ultrafine fibers of hydrogel/polylactide copolymer were successfully electrospun from water‐in‐oil suspensions. Effects of the suspension composition on the morphology and microstructure of the obtained fibers were investigated, including both aqueous phase and oily phase, that is, hydrogel (chitosan or gelatin), polylactide copolymers [poly(ethylene glycol)‐b‐poly (L ‐lactide‐co‐caprolactone) (PELCL) or poly(L ‐lactide‐co‐glycolide) (PLGA)], organic solvents and surfactants. Scanning electron micrographs showed that mixed solvents of chloroform and N,N‐dimethyl formamide or 2,2,2‐trifluoroethanol were preferred to form beads‐free ultrafine fibers with diameter in the range of 230–470 nm. With ethyl acetate as organic solvent, compared with chitosan hydrogel/PELCL composite fibers, chitosan hydrogel/PLGA fibers showed narrower distribution of diameter in 230–590 nm. Different hydrogel and surfactants used in this experiment had slight effects on the morphology of the obtained fibers, whereas transmission electron micrographs exhibited chitosan and gelatin hydrogel could be in situ encapsulated in the fibers discontinuously. This method may promise a new aqueous reservoir for encapsulation and controlled release of bioactive agents. POLYM. ENG. SCI., 2012. © 2012 Society of Plastics Engineers     

Particle size and distribution of biodegradable poly‐D,L‐lactide‐co‐poly(ethylene glycol) block polymer nanoparticles prepared by nanoprecipitation

A biodegradable block copolymer, poly‐D ,L ‐lactide (PLA)‐co‐poly(ethylene glycol) (PEG), was prepared by the ring‐opening polymerization of lactide with stannous caprylate [Sn(Oct₂)] as a catalyst; then, the PLA–PEG copolymer was made into nanoparticles by nanoprecipitation under different conditions. The average molecular weight and structure of PLA–PEG were detected by ¹H‐NMR and gel permeation chromatography. The sizes and distributions of the nanoparticles were investigated with a laser particle‐size analyzer. The morphologies of the nanoparticles were examined by transmission electron microscopy. The effects of the solvent–nonsolvent system, operation conditions, and dosage of span‐80 on the sizes and distributions of the nanoparticles are discussed. The results show that acetone–water was a suitable solvent–nonsolvent system and the volume ratio of the nonsolvent phase to the solvent phase (O/W) (v/v), the concentration of PLA–PEG in the solvent phase, and the dosage of span‐80 had important effects on the particle sizes and distributions. © 2005 Wiley Periodicals, Inc. J Appl Polym Sci 98: 1884–1890, 2005     

Preparation of narrow‐disperse or monodisperse poly{[poly(ethylene glycol) methyl ether acrylate]‐co‐(acrylic acid)} microspheres with ethyleneglycol dimethacrylate as crosslinker by distillation precipitation polymerization

Narrow‐disperse or monodisperse poly{[poly(ethylene glycol) methyl ether acrylate]‐co‐(acrylic acid)} (poly(PEGMA‐co‐AA)) microspheres were prepared by distillation precipitation polymerization with ethyleneglycol dimethacrylate (EGDMA) as crosslinker with 2,2′‐azobisisobutyronitrile as initiator in neat acetonitrile in the absence of any stabilizer, without stirring. The diameters of the resultant poly(PEGMA‐co‐AA‐co‐EGDMA) microspheres were in the range 200–700 nm with a polydispersity index of 1.01–1.14, which depended on the comonomer feed of the polymerization. The addition of the hydrogen bonding monomer acrylic acid played an essential role in the formation of narrow‐disperse or monodisperse polymer microspheres during the polymerization. Copyright © 2006 Society of Chemical Industry     

The polymer free volume as a controlling factor for drug release from poly(lactide‐co‐glycolide) microspheres

Drug release from poly(lactide‐co‐glycolide) (PLGA) microspheres is strongly determined by the pore structure of the particles. This study examines how swelling‐induced pore constriction delays the drug release and by which factors this process is controlled. Combination of different porosimetric and pycnometric methods enabled insight into the submicroscopic range of the pore structure and revealed that remarkably the polymer free volume plays a crucial role in drug release from PLGA microspheres. Surprisingly, the latter was shown to be inversely correlated to the degree of diffusional drug release. This can be explained by a swelling‐induced constriction of the macroporous channel system in the microspheres which is related to the availability of free volume. The hole free volume was shown to be well controllable by the manufacturing conditions. Thus, the study deepens comprehension of the mechanism of drug release from biodegradable microparticles and offers an effective approach for controlling the release behavior. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 39740.     

Preparation of core–shell type nanoparticles of diblock copolymers of poly(L‐lactide)/poly(ethylene glycol) and their characterization in vitro

Core–shell type nanoparticles of poly(L ‐lactide)/poly(ethylene glycol) (LE) diblock copolymer were prepared by a dialysis technique. Their size was confirmed as 40–70 nm using photon correlation spectroscopy. The ¹H‐NMR analysis confirmed the formation of core–shell type nanoparticles and drug loading. The particle size, drug loading, and drug release rate of the LE nanoparticles were slightly changed by the initial solvents that were used. The drug release behavior of LE core–shell type nanoparticles showed an initial burst during the first 12 h and then a sustained release until 100 h. The degradation behavior of LE block copolymer nanoparticles was divided into three phases: the initial rapid degradation phase, the stationary phase, and the rapid degradation phase until complete degradation. It was suggested that lidocaine release kinetics were predominantly governed by the diffusion mechanism in the initial burst phase and after that by both of the diffusion and degradation mechanisms. © 2002 Wiley Periodicals, Inc. J Appl Polym Sci 85: 2625–2634, 2002     

Stereocomplex formation between enantiomeric PLA–PEG–PLA triblock copolymers: Characterization and use as protein‐delivery microparticulate carriers

Two enantiomeric triblock ABA copolymers composed of poly(L ‐lactide)–poly(ethylene glycol)–poly(L ‐lactide) (PLLA–PEG–PLLA) and poly(D ‐lactide)–poly(ethylene glycol)–poly(D ‐lactide) (PDLA–PEG–PDLA) were synthesized with two different middle‐block PEG chain lengths by ring‐opening polymerization of L ‐lactide and D ‐lactide in the presence of PEG, respectively. A pair of enantiomeric triblock copolymers were combined to form a stereocomplex by a solvent‐casting method. The triblock copolymers and their stereocomplexes were characterized by ¹H‐ and ¹³C‐NMR spectroscopy and gel permeation chromatography. Their crystalline structures and crystalline melting behaviors were analyzed by the wide‐angle X‐ray diffraction method and differential scanning calorimetry. The stereocomplex formed between a pair of enantiomeric triblock copolymers exhibited a higher crystalline melting temperature with a distinctive 3/1 helical crystalline structure. PLLA–PEG–PLLA and its stereocomplex with PDLA–PEG–PDLA were used to fabricate a series of microspheres encapsulating a model protein drug, bovine serum albumin (BSA). They were prepared by a double‐emulsion solvent‐evaporation method. The morphological aspects of the microspheres were characterized and BSA release profiles from them were investigated. © 2000 John Wiley & Sons, Inc. J Appl Polym Sci 75: 1615–1623, 2000